Cargando…

Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation

Background: To investigate pro- and anticoagulant alterations in uremic critically ill patients prior to and during continuous renal replacement therapy. In addition to the conventional thrombin generation assay (TGA), we performed a thrombomodulin-modified variant to better elucidate procoagulant i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiegele, Marion, Infanger, Lukas, Lacom, Conrad, Koch, Stefan, Baierl, Andreas, Schaden, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238086/ https://www.ncbi.nlm.nih.gov/pubmed/34195210 http://dx.doi.org/10.3389/fmed.2021.680540

Ejemplares similares

Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
por: Infanger, Lukas, et al.
Publicado: (2021)

Monitoring of Enoxaparin during Hemodialysis Covered by Regional Citrate Anticoagulation in Acute Kidney Injury: A Prospective Cohort Study
por: Wiegele, Marion, et al.
Publicado: (2021)

Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples
por: Lacom, Conrad, et al.
Publicado: (2022)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance
por: Siebeck, M, et al.
Publicado: (2015)

Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy †
por: Laxar, Daniel, et al.
Publicado: (2023)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Impact of CVVHD on pulmonary gas exchange measurement
por: Srámek, V, et al.
Publicado: (1997)

Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation
por: Brain, Matthew J., et al.
Publicado: (2017)

Heparin-induced thrombocytopenia in a non-heparin-naive patient: a case report
por: Wiegele, Marion, et al.
Publicado: (2015)

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement
por: Wiegele, Marion, et al.
Publicado: (2019)

Thrombin generation in different commercial sodium citrate blood tubes
por: Luca, Salvagno Gian, et al.
Publicado: (2020)

Anticoagulants and the Propagation Phase of Thrombin Generation
por: Orfeo, Thomas, et al.
Publicado: (2011)

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
por: Fisher, Richard, et al.
Publicado: (2022)

Comparison of ROTEM parameters from venous and intraosseous blood
por: Wiegele, Marion, et al.
Publicado: (2019)

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
por: Wilson, F. Perry, et al.
Publicado: (2012)

Emergency Production and Collection of Dialysate for CVVHD During the COVID-19 Pandemic
por: Singhala, Mohit, et al.
Publicado: (2021)

Thrombin Generation Biomarkers Decline With Parenteral Anticoagulation—An Overlooked Means of Anticoagulation Monitoring?
por: McFarland, Craig P., et al.
Publicado: (2018)

Carbon dioxide elimination during continuous venovenous hemodiafiltration (CVVHD)-laboratory experiment
por: Ruzicka, J, et al.
Publicado: (2000)

Thrombin generation abnormalities in Quebec platelet disorder
por: Brunet, Justin G., et al.
Publicado: (2020)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

The Production, Efficacy, and Safety of Machine-Generated Bicarbonate Solution for Continuous Venovenous Hemodialysis (CVVHD): The Cleveland Clinic Method
por: Taliercio, Jonathan J., et al.
Publicado: (2021)

Immature Platelet Fraction and Thrombin Generation: Preeclampsia Biomarkers
por: Moraes, Daniela, et al.
Publicado: (2022)

Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Gratz, Johannes, et al.
Publicado: (2021)

Exploring potential anticoagulant drug formulations using thrombin generation test
por: Zavyalova, Elena, et al.
Publicado: (2015)

Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Kallikrein augments the anticoagulant function of the protein C system in thrombin generation
por: Wan, Jun, et al.
Publicado: (2021)

High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic Stress
por: Wu, Li-Hua, et al.
Publicado: (2017)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Complications of regional citrate anticoagulation: accumulation or overload?
por: Schneider, Antoine G., et al.
Publicado: (2017)

Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

STUDIES ON THROMBIN-INDUCED PLATELET AGGLUTINATION
por: Shermer, Richard W., et al.
Publicado: (1961)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets
por: Panova-Noeva, Marina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_07v0e7u1khclnv6ukhohjkljdv